Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates.

导出 OA

翻译打印收藏纠错

作者： Marko,Vidak ^[1] ; Ivana,Jovcevska ^[2] ; Neja,Samec ^[3] ; Alja,Zottel ^[4] ; Mirjana,Liovic ^[5] ; Damjana,Rozman ^[6] ; Saso,Dzeroski ^[7] ; Peter,Juvan ^[8] ; Radovan,Komel ^[9]

作者单位： Faculty of Medicine, Medical Centre for Molecular Biology, University of Ljubljana, Ljubljana SI-1000, Slovenia. marko.vidak@mf.uni-lj.si. ^[1] Faculty of Medicine, Medical Centre for Molecular Biology, University of Ljubljana, Ljubljana SI-1000, Slovenia. ivana.jovcevska@mf.uni-lj.si. ^[2] Faculty of Medicine, Medical Centre for Molecular Biology, University of Ljubljana, Ljubljana SI-1000, Slovenia. neja.samec@mf.uni-lj.si. ^[3] Faculty of Medicine, Medical Centre for Molecular Biology, University of Ljubljana, Ljubljana SI-1000, Slovenia. alja.zottel@mf.uni-lj.si. ^[4] Faculty of Medicine, Medical Centre for Molecular Biology, University of Ljubljana, Ljubljana SI-1000, Slovenia. mirjana.liovic@mf.uni-lj.si. ^[5] Faculty of Medicine, Centre for Functional Genomics and Bio-Chips, University of Ljubljana, Ljubljana SI-1000, Slovenia. damjana.rozman@mf.uni-lj.si. ^[6] Department of Knowledge Technologies, Jozef Stefan Institute, Ljubljana SI-1000, Slovenia. saso.dzeroski@ijs.si. ^[7] Faculty of Medicine, Centre for Functional Genomics and Bio-Chips, University of Ljubljana, Ljubljana SI-1000, Slovenia. peter.juvan@mf.uni-lj.si. ^[8] Faculty of Medicine, Medical Centre for Molecular Biology, University of Ljubljana, Ljubljana SI-1000, Slovenia. radovan.komel@mf.uni-lj.si. ^[9]

关键词 FREM2 SPRY1 biomarkers cell surface data repositories experimental validation glioblastoma glioblastoma stem cells meta-analysis